247 related articles for article (PubMed ID: 11929952)
1. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.
Agrawal D; Chen T; Irby R; Quackenbush J; Chambers AF; Szabo M; Cantor A; Coppola D; Yeatman TJ
J Natl Cancer Inst; 2002 Apr; 94(7):513-21. PubMed ID: 11929952
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin identified as colon cancer tumor progression marker.
Agrawal D; Chen T; Irby R; Quackenbush J; Chambers AF; Szabo M; Cantor A; Coppola D; Yeatman TJ
C R Biol; 2003; 326(10-11):1041-3. PubMed ID: 14744111
[TBL] [Abstract][Full Text] [Related]
3. Expression of the antiapoptotic protein survivin in colon cancer.
Hernandez JM; Farma JM; Coppola D; Hakam A; Fulp WJ; Chen DT; Siegel EM; Yeatman TJ; Shibata D
Clin Colorectal Cancer; 2011 Sep; 10(3):188-93. PubMed ID: 21855041
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.
Kita H; Hikichi Y; Hikami K; Tsuneyama K; Cui ZG; Osawa H; Ohnishi H; Mutoh H; Hoshino H; Bowlus CL; Yamamoto H; Sugano K
J Gastroenterol; 2006 Nov; 41(11):1053-63. PubMed ID: 17160516
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin and colon cancer progression.
Yeatman TJ; Chambers AF
Clin Exp Metastasis; 2003; 20(1):85-90. PubMed ID: 12650611
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling identifies markers of ampullary adenocarcinoma.
Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
[TBL] [Abstract][Full Text] [Related]
8. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract][Full Text] [Related]
9. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.
Coppola D; Szabo M; Boulware D; Muraca P; Alsarraj M; Chambers AF; Yeatman TJ
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):184-90. PubMed ID: 14734468
[TBL] [Abstract][Full Text] [Related]
10. Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
Mills GB; Bast RC; Srivastava S
J Natl Cancer Inst; 2001 Oct; 93(19):1437-9. PubMed ID: 11584052
[No Abstract] [Full Text] [Related]
11. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
[TBL] [Abstract][Full Text] [Related]
12. Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.
Zhu JS; Guo H; Song MQ; Chen GQ; Sun Q; Zhang Q
World J Gastroenterol; 2008 Oct; 14(38):5887-92. PubMed ID: 18855989
[TBL] [Abstract][Full Text] [Related]
13. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation.
Chernaya G; Mikhno N; Khabalova T; Svyatchenko S; Mostovich L; Shevchenko S; Gulyaeva L
Surg Oncol; 2018 Dec; 27(4):702-708. PubMed ID: 30449496
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin as a potential diagnostic biomarker for ovarian cancer.
Kim JH; Skates SJ; Uede T; Wong KK; Schorge JO; Feltmate CM; Berkowitz RS; Cramer DW; Mok SC
JAMA; 2002 Apr; 287(13):1671-9. PubMed ID: 11926891
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin hybrid protein gene expression during human colon cancer progression.
Mafune K; Wong JM; Staniunas RJ; Lu ML; Ravikumar TS; Chen LB; Steele GD
Arch Surg; 1991 Apr; 126(4):462-6. PubMed ID: 2009061
[TBL] [Abstract][Full Text] [Related]
16. Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Fisher LW; Jain A; Tayback M; Fedarko NS
Clin Cancer Res; 2004 Dec; 10(24):8501-11. PubMed ID: 15623631
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp.
Gonzalo DH; Lai KK; Shadrach B; Goldblum JR; Bennett AE; Downs-Kelly E; Liu X; Henricks W; Patil DT; Carver P; Na J; Gopalan B; Rybicki L; Pai RK
J Pathol; 2013 Aug; 230(4):420-9. PubMed ID: 23595865
[TBL] [Abstract][Full Text] [Related]
18. Distinct gene expression of osteopontin in patients with ulcerative colitis.
Masuda H; Takahashi Y; Asai S; Takayama T
J Surg Res; 2003 May; 111(1):85-90. PubMed ID: 12842452
[TBL] [Abstract][Full Text] [Related]
19. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma.
Gay F; Estornes Y; Saurin JC; Joly-Pharaboz MO; Friederich E; Scoazec JY; Abello J
Hum Pathol; 2008 Oct; 39(10):1420-30. PubMed ID: 18656242
[TBL] [Abstract][Full Text] [Related]
20. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
